Cargando…

Potential role of Chinese medicine nanoparticles to treat coronary artery disease

Coronary artery disease (CAD) is a leading cause of death worldwide, while conventional treatments such as percutaneous coronary intervention (PCI) have limitations. This review aims to explore the potential of nanoparticles loaded with Chinese medicine in the treatment of CAD. We conducted a compre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Rongyuan, Gu, Yingming, Qin, Jinying, Liu, Qingqing, Liu, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559060/ https://www.ncbi.nlm.nih.gov/pubmed/37809499 http://dx.doi.org/10.1016/j.heliyon.2023.e19766

Ejemplares similares

Traditional Chinese Medicine Targeting Heat Shock Proteins as Therapeutic Strategy for Heart Failure
por: Wang, Yanchun, et al.
Publicado: (2022)

Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Zhu, Decai, et al.
Publicado: (2023)

The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease
por: Yang, Xinyu, et al.
Publicado: (2019)

Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials
por: Liang, Bo, et al.
Publicado: (2021)

In Silico Syndrome Prediction for Coronary Artery Disease in Traditional Chinese Medicine
por: Lu, Peng, et al.
Publicado: (2012)

Chinese patent medicines for coronary microvascular disease: clinical evidence and potential mechanisms
por: Yang, Zhihua, et al.
Publicado: (2023)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease
por: Chen, Kuen-Bao, et al.
Publicado: (2016)

Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease
por: Yuan, Rong, et al.
Publicado: (2018)

The effectiveness of acupoint application of traditional Chinese medicine in treating primary dysmenorrhea: A protocol for meta-analysis and data mining
por: Liu, Yanze, et al.
Publicado: (2021)

Serum N (1)‐Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients
por: Liu, Ming, et al.
Publicado: (2017)

Potential Retinoid X Receptor Agonists for Treating Alzheimer's Disease from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Evaluation of the safety and efficacy of a Polyzene-F nanocoated coronary stent system: A systematic review and single-arm meta-analysis
por: Bian, Jifang, et al.
Publicado: (2023)

Molecular mechanism of Chuanxiong Rhizoma in treating coronary artery diseases
por: Yin, Bang-qiao, et al.
Publicado: (2021)

Blood lead level in Chinese adults with and without coronary artery disease
por: LI, Shi-Hong, et al.
Publicado: (2021)

Associations of Mitochondrial Variants With Lipidomic Traits in a Chinese Cohort With Coronary Artery Disease
por: Wang, Zixian, et al.
Publicado: (2021)

The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis
por: Lu, Yi-Chin, et al.
Publicado: (2022)

Association of Epicardial Fat Volume With Increased Risk of Obstructive Coronary Artery Disease in Chinese Patients With Suspected Coronary Artery Disease
por: Yu, Wenji, et al.
Publicado: (2021)

Modelling of inquiry diagnosis for coronary heart disease in traditional Chinese medicine by using multi-label learning
por: Liu, Guo-Ping, et al.
Publicado: (2010)

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
por: Cheng, Tian-Yi, et al.
Publicado: (2021)

Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
por: Yang, Xiuli, et al.
Publicado: (2023)

Chinese Medicine for Treating Endocrinology-Related Disease
por: Xin, Yizhou, et al.
Publicado: (2015)

Influence of obstructive sleep apnoea on coronary artery disease in a Chinese population
por: Liu, Yufei, et al.
Publicado: (2022)

Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
por: Zhu, Ruirui, et al.
Publicado: (2015)

Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2021)

Association of Frailty With Antiplatelet Response Among Elderly Chinese Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yang, et al.
Publicado: (2020)

Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine
por: Lin, Fei, et al.
Publicado: (2020)

Polymorphism in ERCC1 confers susceptibility of coronary artery disease and severity of coronary artery atherosclerosis in a Chinese Han population
por: Zhang, Shuai, et al.
Publicado: (2017)

NEXN Is a Novel Susceptibility Gene for Coronary Artery Disease in Han Chinese
por: Wu, Chong, et al.
Publicado: (2013)

Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome
por: Wang, Jiayu, et al.
Publicado: (2022)

Mechanism of traditional Chinese medicine in treating overactive bladder
por: Liao, Yuxiang, et al.
Publicado: (2022)

Musings on genome medicine: cholesterol and coronary artery disease
por: Nathan, David G, et al.
Publicado: (2009)

Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms
por: Zhang, Ke-Jian, et al.
Publicado: (2019)

Coronary artery bypass grafting vs. percutaneous coronary intervention in coronary artery disease patients with advanced chronic kidney disease: A Chinese single-center study
por: Li, Yang, et al.
Publicado: (2023)

Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention
por: Pan, Yu, et al.
Publicado: (2021)

The Association between the LPA Gene Polymorphism and Coronary Artery Disease in Chinese Han Population
por: Song, Zi-Kai, et al.
Publicado: (2014)

Corrigendum: Atherogenic index of plasma and coronary artery disease in the adult population: A meta-analysis
por: Wu, Jing, et al.
Publicado: (2023)

The signaling pathways of traditional Chinese medicine in treating diabetic retinopathy
por: Li, Wencan, et al.
Publicado: (2023)

Prevalence of familial hypercholesterolemia and its association with coronary artery disease: A Chinese cohort study
por: Aihaiti, Xiapikatijiang, et al.
Publicado: (2023)

The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture
por: Teng, Nathaniel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ho7f1ohpm1ndv0gam2b67hrq1h